Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease
There is increasing importance placed upon noninvasive assessment of gut inflammation. These tools are likely to be the key in differentiating intestinal inflammatory disease from functional disorders and in monitoring the response to intervention in individuals with known inflammatory conditions. A...
Saved in:
Main Authors: | Gilles Duvoisin, Robert N. Lopez, Andrew S. Day, Daniel A. Lemberg, Richard B. Gearry, Steven T. Leach |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2017/1936315 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inflammatory Bowel Disease in Children of Middle Eastern Descent
by: Christina Mai Ying Naidoo, et al.
Published: (2014-01-01) -
Paediatric Inflammatory Bowel Disease: A Mechanistic Approach to Investigate Exclusive Enteral Nutrition Treatment
by: Lily Nahidi, et al.
Published: (2014-01-01) -
Comment on “Biomarkers as Potential Treatment Targets in Inflammatory Bowel Disease: A Systematic Review”
by: Nicholas-Paul Delicata, et al.
Published: (2016-01-01) -
Biomarkers in Inflammatory Bowel Disease-Associated Spondyloarthritis: State of the Art and Unmet Needs
by: Devis Benfaremo, et al.
Published: (2019-01-01) -
Evaluation of Serum Leucine-Rich Alpha-2 Glycoprotein as a New Inflammatory Biomarker of Inflammatory Bowel Disease
by: Tetsuhiro Yoshimura, et al.
Published: (2021-01-01)